Bio-Rad announces collaboration agreement with oncocyte to commercialize transplant monitoring with droplet digital PCR

John­son & John­son un­veiled long-term ex­ten­sion da­ta on Sat­ur­day for a pro­gram it hopes can com­pete with Bris­tol My­ers Squibb’s So­tyk­tu in plaque pso­ri­a­sis. Re­sults

On­col­o­gy and res­pi­ra­to­ry drug de­vel­op­er in­voX Phar­ma is fine-tun­ing its pipeline and ex­pects to cut about one-third of its em­ploy­ees, the com­pa­ny con­firmed to …